7 Tesla MRI Sheds Light on END Mechanisms in Symptomatic MCA Stenosis
International Journal of Stroke (IJS) posted on X:
”7T to investigate plaque features and LSA morphology in unexplained early neurological deterioration (END) in symptomatic MCA stenosis
END risk factors:
- Larger infarct size
- Higher LDL level
- Plaques located at openings of LSA on MCA”
Read the full article here.
A recent study using 7 Tesla (7T) MRI explored plaque characteristics and lenticulostriate artery (LSA) morphology in patients with symptomatic middle cerebral artery (MCA) stenosis and unexplained early neurological deterioration (END).
Findings identified key risk factors for END, including larger infarct size, elevated LDL levels, and plaques located at the openings of LSAs on the MCA wall.
These high-resolution insights highlight the potential of ultra-high-field imaging to improve risk stratification and guide targeted interventions in intracranial atherosclerotic disease.
Hemostasis Today, your daily news on stroke.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis